Quick Answer (for busy buyers)
Here’s the buyer-first summary. If your brand name is on the label, you usually act as the responsible person and must ensure the listing is submitted and kept current.
- A Certificate of Analysis (COA) is a mandatory quality document for hair care products like shampoo, conditioner, hair mask, and scalp serum in the EU.
- It confirms each batch meets specified standards under EU Regulation EC No 1223/2009, ensuring traceability and safety for consumers.
- Without a proper COA, products cannot be legally sold or imported into the EU market, risking non-compliance penalties or recalls.
- Key inclusions are product name and code, batch number, production and expiry dates, manufacturer details, and test parameters with acceptance limits.
- For hair care, typical tests cover pH (4.0-7.0 for most), viscosity, microbial limits (e.g., <100 CFU/g for bacteria), heavy metals (lead, arsenic), preservative efficacy, and stability data under accelerated conditions.
- The COA must also state compliance with EU cosmetic product safety reports and ingredient restrictions, such as banned substances or allergen labeling.
- From a factory perspective, generating a COA involves batch-specific testing after production, which adds 1-2 weeks to lead time depending on lab capacity.
- MOQ influences this: smaller batches may have higher per-unit testing costs, while larger batches ensure consistency and cost efficiency.
- Sampling for COA requires pilot batches to validate formulations, with timelines of 3-4 weeks for testing and documentation.
- Packaging must be validated for compatibility to prevent leaching or contamination, affecting COA stability claims.
- We support by conducting in-house or third-party tests, providing draft COAs for review, and assisting with documentation for EU notifications, but final regulatory approval depends on authorities.
- Always factor in COA preparation when planning launch dates to avoid delays.
Buyer outcome
A launch-ready compliance plan: inputs collected, roles assigned, and update cadence defined.
Most common blocker
Missing facility information + inconsistent ingredient/label snapshots across SKUs.
⚠️
This page is a practical buyer guide. For definitive requirements and updates, use FDA resources and qualified regulatory counsel.